全文获取类型
收费全文 | 67728篇 |
免费 | 7015篇 |
国内免费 | 4554篇 |
专业分类
耳鼻咽喉 | 626篇 |
儿科学 | 1015篇 |
妇产科学 | 764篇 |
基础医学 | 7350篇 |
口腔科学 | 1330篇 |
临床医学 | 9030篇 |
内科学 | 9539篇 |
皮肤病学 | 599篇 |
神经病学 | 3300篇 |
特种医学 | 2438篇 |
外国民族医学 | 34篇 |
外科学 | 6276篇 |
综合类 | 12463篇 |
现状与发展 | 15篇 |
一般理论 | 17篇 |
预防医学 | 5645篇 |
眼科学 | 1747篇 |
药学 | 7480篇 |
69篇 | |
中国医学 | 4129篇 |
肿瘤学 | 5431篇 |
出版年
2024年 | 292篇 |
2023年 | 1131篇 |
2022年 | 2965篇 |
2021年 | 3693篇 |
2020年 | 2997篇 |
2019年 | 2204篇 |
2018年 | 2376篇 |
2017年 | 2260篇 |
2016年 | 2148篇 |
2015年 | 3328篇 |
2014年 | 3882篇 |
2013年 | 3725篇 |
2012年 | 5546篇 |
2011年 | 5698篇 |
2010年 | 3884篇 |
2009年 | 3135篇 |
2008年 | 3742篇 |
2007年 | 3759篇 |
2006年 | 3639篇 |
2005年 | 3317篇 |
2004年 | 2364篇 |
2003年 | 2274篇 |
2002年 | 1872篇 |
2001年 | 1243篇 |
2000年 | 1161篇 |
1999年 | 1174篇 |
1998年 | 707篇 |
1997年 | 741篇 |
1996年 | 567篇 |
1995年 | 568篇 |
1994年 | 454篇 |
1993年 | 297篇 |
1992年 | 347篇 |
1991年 | 333篇 |
1990年 | 281篇 |
1989年 | 208篇 |
1988年 | 171篇 |
1987年 | 161篇 |
1986年 | 133篇 |
1985年 | 104篇 |
1984年 | 88篇 |
1983年 | 43篇 |
1982年 | 45篇 |
1981年 | 33篇 |
1980年 | 24篇 |
1979年 | 27篇 |
1978年 | 12篇 |
1977年 | 9篇 |
1974年 | 9篇 |
1973年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
29例非胰岛素依赖型糖尿病合并周围神经病变患者分成两组:一组为控制血糖组共12例,经8个月严格控制血糖,正中、尺、腓运动神经传导速度和正中、尺感觉神经潜伏期获改善,而且改善的程度与空腹血糖和糖基化血红蛋白降低的程度密切相关;另一组为针灸加控制血糖组共17例,经1与3个月的治疗,分别有82.4%和90.0%的患者神经病变临床症状得到改善,但正中、尺、腓运动神经传导速度和正中、尺感觉神经潜伏期未得到改善。 相似文献
92.
L H Ren A V Vasil'ev A N Orkehov V V Tertov V A Tutel'ian 《Farmakologiia i toksikologiia》1989,52(5):44-46
Administration of alizole, berberine, pheonol and pheoniphlorine in doses of 30-100 micrograms/ml in the culture of the atherosclerotic human aortic intimal cells decreased the content of intracellular cholesterol by 35-41% and reduced the proliferative activity of the cells. In healthy donors administration of single doses of berberine and pheoniphlorine (0.9 g) increased the antiatherogenic potential of the serum which was estimated on the primary culture of the intimal cells. 相似文献
93.
94.
越来越多的研究表明,维生素D除具有经典的调节钙磷平衡和维持骨骼健康的作用外,还具有其他更为广泛的骨外生物学效应,如调节免疫、抗肿瘤、保护中枢神经系统和防治代谢综合征等作用.本文就相关方面的研究进展进行综述. 相似文献
95.
目的:认识睾丸微石症(TM)的临床意义和诊断方法。方法:回顾性报告2例TM病例的临床资料,结合文献进行讨论。结果:2例分别因左精索静脉曲张和附睾炎就诊的患者行阴囊超声检查时发现睾丸内散在多发点状强回声,如针尖样,1~2mm,后无声影。分别诊断为局部TM、左精索静脉曲张和TM,左附睾炎。甲胎蛋白、人绒毛膜促性腺激素、乳酸脱氢酶和睾酮等检查均正常。对睾丸微石症未做特殊处置,随访6~8个月,体检和睾丸瘤标未见异常,阴囊超声睾丸图像无特征性改变。结论:TM是一种少见、无明显临床症状、相对稳定的疾病。多因阴囊其他疾病行超声检查时偶然发现,其是否属于癌前病变尚有争议,但是定期随访和阴囊超声检查是必要的。 相似文献
96.
A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases. 总被引:3,自引:0,他引:3
Pavel Sova Xiao-Wei Ren Shaoheng Ni Kathrin M Bernt Jie Mi Nancy Kiviat André Lieber 《Molecular therapy》2004,9(4):496-509
We have constructed a new capsid-modified adenovirus (Ad) vector that specifically replicates in tumor cells and expresses TNF-related apoptosis-inducing ligand (TRAIL). The Ad capsid contains short-shafted fibers derived from Ad serotype 35, which allow for efficient infection of malignant tumor cells, and largely avoids innate toxicity after intravenous application. Replication-dependent homologous recombination in Ad genomes was used to achieve tumor-specific expression of Ad E1a (to mediate viral replication) and TRAIL (to mediate apoptosis and enhance release of progeny virus from infected cells). We demonstrated that our oncolytic vector (Ad5/35.IR-E1A/TRAIL) induced apoptosis in human tumor cell lines derived from colorectal, lung, prostate, and liver cancer. Both in vitro and in vivo tumor models showed efficient intratumoral spread of this vector. In a model for metastatic colon cancer, tail vein infusion of Ad5/35.IR-E1A/TRAIL resulted in elimination of preestablished liver metastases. Intravenous injection of this vector caused a transient elevation of serum glutamic pyruvic transaminase in tumor-bearing mice, which we attributed to factors released from apoptotic tumor cells. Liver histology analyzed at day 14 after virus injection did not show signs of hepatocellular damage. This new oncolytic vector represents a potentially efficient means for gene therapy of metastatic cancer. 相似文献
97.
氧化苦参碱抑制人肝癌细胞EGF和EGFR表达的研究 总被引:3,自引:0,他引:3
目的:探讨氧化苦参碱对人肝癌细胞EGF及EGFR表达的影响。方法:将肝癌细胞株BEL-7402在37℃、5%CO2条件下培养、传代。按氧化苦参碱浓度分为1000μg/ml、500μg/ml、250μg/ml3组,对照组不加氧化苦参碱,每组设6个平行孔,每孔加入细胞1×105/ml,培养24h、48h和72h,分别进行EGF及EGFR的免疫组化染色。结果:不同浓度的氧化苦参碱均抑制EGF和EGFR在人肝癌细胞的表达,随着培养时间的延长,EGF和EGFR表达阳性率下降显著,在1000μg/ml组24h、48h和72h的EGF和EGFR阳性率均较500μg/ml组和250μg/ml组同时段的阳性率下降显著(P〈0.05,P〈0.01)。500μg/ml组和250μg/ml组同时段的阳性率无明显差异。结论:氧化苦参碱对EGF和EGFR的抑制途径可能是其抗肝癌机制之一。 相似文献
98.
Defective implant osseointegration under protein undernutrition: prevention by PTH or pamidronate. 总被引:1,自引:0,他引:1
Romain Dayer Isabelle Badoud René Rizzoli Patrick Ammann 《Journal of bone and mineral research》2007,22(10):1526-1533
Protein deficiency is associated with impaired titanium osseointegration. We studied whether systemic treatment with PTH or pamidronate could influence the resistance to pull-out of titanium rods implanted into rats proximal tibia under normal and isocaloric low protein intake. PTH or pamidronate prevented the deleterious effects of protein undernutrition on bone microarchitecture close to the implant and on mechanical fixation. PTH even significantly improved implant osseointegration. INTRODUCTION: Protein deficiency is highly prevalent among elderly patients hospitalized in orthopedic wards. Reduced protein intake impairs titanium osseointegration in rats. Whether stimulator of bone formation or inhibitor of bone resorption could improve implant osseointegration under protein deprivation is not known. We studied the effects of systemic treatment with PTH or pamidronate on the resistance to pull-out of titanium rods implanted into rats proximal tibia under normal and isocaloric low protein intake. MATERIALS AND METHODS: We measured the resistance to pull-out 1-mm-diameter titanium rods implanted into the proximal tibias of 49 adult female rats receiving a normal or an isocaloric low protein diet. After 2 wk on either diet, the implants were inserted, and the rats received PTH(1-34), pamidronate or saline vehicle for 8 wk. The tibias were removed for microCT morphometry, followed by the evaluation of pull-out strength. RESULTS: Pull-out strength was lower in rats fed an isocaloric low protein diet compared with rats fed a normal protein intake (-29%). PTH and pamidronate significantly increased pull-out strength in animals fed a normal or a low protein diet, the effect of PTH being of higher magnitude. The PTH- or pamidronate-mediated increase in pull-out strength was associated with significant increases of relative bone volume, bone-to-implant contact, and trabecular thickness, whereas trabecular spacing was reduced, in the vicinity of the implants. CONCLUSIONS: We confirmed that isocaloric low protein intake impairs titanium implant osseointegration. PTH or pamidronate prevented the deleterious effects of protein undernutrition and even significantly improved the implant osseointegration. These results indicate that systemic administration of PTH or pamidronate could be considered for preventing uncemented arthroplasty loosening in protein undernourished patients. 相似文献
99.
100.
Jacobo E Mintzer Larry E Tune Christopher D Breder René Swanink Ronald N Marcus Robert D McQuade Andy Forbes 《The American journal of geriatric psychiatry》2007,15(11):918-931
OBJECTIVE: To assess the efficacy and safety of aripiprazole for psychosis associated with Alzheimer dementia (AD). METHODS: In this double-blind, multicenter study, 487 institutionalized patients with psychosis associated with AD were randomized to placebo or aripiprazole, 2, 5 or 10 mg/day. Primary efficacy assessment was the mean change from baseline to week 10 on the Neuropsychiatric Inventory-Nursing Home (NPI-NH) version Psychosis Subscale score. Secondary measures included NPI-NH Total, Clinical Global Impression-Severity of Illness (CGI-S), Brief Psychiatric Rating Scale (BPRS) Core and Total, and the Cohen-Mansfield Agitation Inventory (CMAI) scores. RESULTS: Aripiprazole 10 mg/day showed significantly greater improvements (mean change [2 x SD]) than placebo on the NPI-NH Psychosis Subscale (-6.87 [8.6] versus -5.13 [10.0]; F = 6.29, df = 1, 422, p = 0.013 by analysis of covariance [ANCOVA]); CGI-S (-0.72 [1.8] versus -0.46 [1.6]; F = 4.68, df = 1, 419, p = 0.031 [ANCOVA]); BPRS Total (-7.12 [18.4] versus -4.17 [21.6]; F = 4.72, df = 1, 399, p = 0.030 [ANCOVA]); BPRS Core (-3.07 [6.9] versus -1.74 [7.8]; F = 7.30, df = 1, 407, p = 0.007 [ANCOVA]); CMAI (-10.96 [22.6] versus -6.64 [28.6]; F = 5.23, df = 1, 410, p = 0.023 [ANCOVA]), and NPI-NH Psychosis response rate (65 versus 50%; chi(2) = 5.52, df = 1, p = 0.019 [CMH]). Aripiprazole 5 mg/day showed significant improvements versus placebo on BPRS and CMAI scores. Aripiprazole 2 mg/day was not efficacious. Cerebrovascular adverse events were reported: aripiprazole 2 mg/day, N = 1; 5 mg/day, N = 2; 10 mg/day, N = 4; placebo, N = 0. No deaths in any group (aripiprazole 2 mg/day, 3%; 5 mg/day, 2%; 10 mg/day, 7%; placebo, 3%) were considered to be treatment-related. CONCLUSION: Aripiprazole 10 mg/day was efficacious and safe for psychosis associated with AD, significantly improving psychotic symptoms, agitation, and clinical global impression. However, clinicians should be aware of the safety considerations of atypical antipsychotic uses in this population. 相似文献